Latest filing published 03 Jun 2024 for Humacyte, Inc., €441k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Heather Ledbetter Prichard: trading record in brief
This profile gathers the share dealings of Heather Ledbetter Prichard in Humacyte, Inc., where the filings describe the role as senior executive. Between 26 August 2021 and 31 May 2024, the trades on record add up to 12 filings.
The open-market record consists of 6 sales worth €1.5M, with no purchase. Other entries cover 1 share grant and 5 option exercises. Since January 2024: no purchases and 4 sales on the market.
On 3 June 2024 came the latest disclosure, an open-market sale for €608k in Humacyte, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Heather Ledbetter Prichard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 61,941 shares@ US$7.7195.2% of flowCommon StockSEC:0001818382-24-000074:0
- 13,789 shares@ US$1.193.3% of flowCommon StockSEC:0001104659-23-065547:0
- 6,564 shares@ US$1.151.5% of flowCommon StockSEC:0001818382-22-000203:0
- 2,625 sharesCommon StockSEC:0001104659-21-110525:0
4 of 4 declarations